Natalie Schellack Selected Research

Natalie Schellack Research Topics

5	Infections 01/2023 - 01/2020
4	Respiratory Tract Infections (Respiratory Tract Infection) 10/2023 - 01/2020
4	COVID-19 02/2023 - 01/2020
3	Ototoxicity 01/2020 - 06/2015
3	Tuberculosis (Tuberculoses) 01/2020 - 11/2017
2	Critical Illness (Critically Ill) 05/2024 - 01/2023
2	Fever (Fevers) 01/2022 - 09/2021
1	Neuralgia (Stump Neuralgia) 07/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2023
1	Common Cold 01/2023
1	Cytokine Release Syndrome 03/2022
1	Urinary Tract Infections (Urinary Tract Infection) 03/2022
1	Surgical Wound Infection 06/2021
1	Virus Diseases (Viral Diseases) 06/2021
1	Anastomotic Leak 01/2021
1	Sinusitis 01/2020
1	Allergic Rhinitis 01/2020
1	Human Influenza (Influenza) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 08/2018
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Gram-Negative Bacterial Infections 01/2018
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2017

12	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 11/2017
2	VaccinesIBA 06/2021 - 01/2020
1	Vitamin B Complex (B Vitamins)IBA 07/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Antitussive Agents (Antitussives)FDA Link 01/2023
1	Histamine Antagonists (Antihistamines)IBA 01/2023
1	Plant ExtractsIBA 01/2023
1	Nasal Decongestants (Decongestants)IBA 01/2023
1	AntipyreticsIBA 01/2023
1	QuercetinIBA 03/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2022
1	sarilumabIBA 03/2022
1	InterleukinsIBA 03/2022
1	CytokinesIBA 03/2022
1	InflammasomesIBA 03/2022
1	tocilizumab (atlizumab)FDA Link 03/2022
1	NLR ProteinsIBA 03/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2022
1	LactamsIBA 01/2022
1	tazobactam drug combination ceftolozaneIBA 01/2022
1	ceftazidime drug combination avibactamIBA 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	AminoglycosidesIBA 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	beta-Lactamase InhibitorsIBA 04/2019
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2018
1	Colistin (Coly-Mycin)FDA Link 01/2018
1	Metronidazole (Metric)FDA LinkGeneric 10/2017
1	Doxycycline (Periostat)FDA LinkGeneric 10/2017
1	Ciprofloxacin (Cipro)FDA LinkGeneric 10/2017

3	Drug Therapy (Chemotherapy) 11/2019 - 06/2015
1	Therapeutics 05/2024
1	Self Medication 02/2023
1	Ambulatory Care (Outpatient Care) 06/2021
1	Inappropriate Prescribing 06/2021
1	Parenteral Nutrition 01/2021
1	Length of Stay 12/2020